Publicaciones en colaboración con investigadores/as de Boston University School of Medicine (12)

2024

  1. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

    Skeletal Radiology, Vol. 53, Núm. 11, pp. 2409-2416

2023

  1. Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort

    Skeletal Radiology, Vol. 52, Núm. 7, pp. 1339-1348

  2. Machine-learning predicted and actual 2-year structural progression in the IMI-APPROACH cohort

    Quantitative Imaging in Medicine and Surgery, Vol. 13, Núm. 5, pp. 3298-3306

  3. Quantitative CT of the knee in the IMI-APPROACH osteoarthritis cohort: Association of bone mineral density with radiographic disease severity, meniscal coverage and meniscal extrusion

    Bone, Vol. 168

  4. Test–retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort

    Osteoarthritis and Cartilage, Vol. 31, Núm. 2, pp. 238-248

2022

  1. Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

    Annals of the Rheumatic Diseases

  2. Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort

    BMC Musculoskeletal Disorders, Vol. 23, Núm. 1

2020

  1. Subcutaneous tanezumab for osteoarthritis of the hip or knee: Efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 6, pp. 800-810

2018

  1. Mitochondrial DNA haplogroups associated with MRI-detected structural damage in early knee osteoarthritis

    Osteoarthritis and Cartilage, Vol. 26, Núm. 11, pp. 1562-1569

2015

  1. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use

    Osteoarthritis and Cartilage, Vol. 23, Núm. 8, pp. 1233-1241

  2. OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis

    Osteoarthritis and Cartilage, Vol. 23, Núm. 5, pp. 686-697

2014

  1. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies

    Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949